Trending Now

Seattle’s big three institutes launch $95M AI BioDesign accelerator

Allen Institute, UW and Fred Hutch launch the $95M AI BioDesign accelerator…

Europe approves Vara’s AI to clear normal mammograms on its own

Vara's AI can now report clearly normal mammograms alone after a landmark…

Hospital-built AI screens myeloma trial candidates in seconds

Seoul St. Mary's Hospital built in-house AI that screens myeloma patients for…

Veeva’s Falcon Safety agents take over drug side-effect reporting

Veeva's Falcon Safety agents automate adverse event intake, case processing and follow-up…

Medtronic backs Hong Kong robot maker with $700M for global sales

Medtronic puts $700M behind Cornerstone Robotics and gains rights to sell its…

AI Emerges as a Game-Changer in Humanitarian Healthcare Crisis Response

AI is being harnessed to transform humanitarian healthcare, improving disaster response, disease surveillance, mental health…

HKUST Pioneers Micro-Robotics and AI Tools to Reshape Global Healthcare

From ultra-miniature surgical robots to gamified respiratory monitors, HKUST is redefining medical technology with innovations…

High-Quality Data Is Key to Unlocking AI’s Full Potential in Clinical Trials

AI is streamlining clinical trials and cutting drug development costs, but success hinges on data…

Bioptimus folds UK colorectal data into AI tissue atlas

Bioptimus gains a 1,750-patient UK colorectal dataset to train its STELA tissue atlas foundation model.

By

GenBio launches stateful AIDO Cell to simulate whole human cells

GenBio AI launches AIDO Cell, a stateful virtual cell that predicts how DNA, RNA and…

By

Perioperative nurses group issues AI safety guidance for operating rooms

AORN releases new perioperative guidance urging continuous AI governance and clinician accountability in surgical settings.

By

One voice foundation model could unite ALS and Parkinson’s tracking

A new npj Digital Medicine perspective urges one shared voice model for ALS and Parkinson's…

By

Tempus AI acquires Personalis for $1.5B in precision medicine play

Tempus AI adds Personalis' liquid biopsy and tumor sequencing capabilities in a $1.5 billion acquisition.

By

Guangdong Medical University Launches China’s First AI Medical School to Lead Future Healthcare Education

The newly launched AI Medical School integrates virtual reality, digital twins, and large AI models…

Designing Healthcare AI for Real World Clinical Flow

A Microsoft Health AI engineer explains why the biggest barrier to clinical AI adoption is…

By

OpenEvidence and Boston Children’s partner to study AI’s clinical impact

OpenEvidence and Boston Children's Hospital launched a multi-year study to evaluate how AI tool use…

By